Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,991 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.
Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, John Gill M, Touloumi G, Vourli G, Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, D'Arminio Monforte A, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA; Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration. Cain LE, et al. Among authors: moreno s. Int J Epidemiol. 2016 Dec 1;45(6):2038-2049. doi: 10.1093/ije/dyv295. Int J Epidemiol. 2016. PMID: 26721599 Free PMC article.
Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study.
Perez-Elias MJ, Garcia-Arota I, Muñoz V, Santos I, Sanz J, Abraira V, Arribas JR, González J, Moreno A, Dronda F, Antela A, Pumares M, Martí-Belda P, Casado JL, Geijos P, Moreno S; Realvirfen study group. Perez-Elias MJ, et al. Among authors: moreno s, moreno a. Antivir Ther. 2003 Dec;8(6):577-84. Antivir Ther. 2003. PMID: 14760891 Clinical Trial.
Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
Rodríguez-Arenas MA, Jarrín I, del Amo J, Iribarren JA, Moreno S, Viciana P, Peña A, Sirvent JL, Vidal F, Lacruz J, Gutierrez F, Oteo JA, Asencio R, Castilla J, Hoyos SP; CoRIS-MD. Rodríguez-Arenas MA, et al. Among authors: moreno s. AIDS Res Hum Retroviruses. 2006 Aug;22(8):715-23. doi: 10.1089/aid.2006.22.715. AIDS Res Hum Retroviruses. 2006. PMID: 16910826
Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.
Gutierrez F, Padilla S, Masiá M, Iribarren JA, Moreno S, Viciana P, Muñoz L, Gómez Sirvent JL, Vidal F, López-Aldeguer J, Blanco JR, Leal M, Rodríguez-Arenas MA, Perez Hoyos S; CoRIS-MD. Gutierrez F, et al. Among authors: moreno s. PLoS One. 2006 Dec 20;1(1):e89. doi: 10.1371/journal.pone.0000089. PLoS One. 2006. PMID: 17183720 Free PMC article. Clinical Trial.
[Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results].
Caro-Murillo AM, Castilla J, Pérez-Hoyos S, Miró JM, Podzamczer D, Rubio R, Riera M, Viciana P, López Aldeguer J, Iribarren JA, de los Santos-Gil I, Gómez-Sirvent JL, Berenguer J, Gutiérrez F, Saumoy M, Segura F, Soriano V, Peña A, Pulido F, Oteo JA, Leal M, Casabona J, del Amo J, Moreno S; Grupo de trabajo de la Cohorte de la Red de Investigación en Sida (CoRIS). Caro-Murillo AM, et al. Among authors: moreno s. Enferm Infecc Microbiol Clin. 2007 Jan;25(1):23-31. doi: 10.1157/13096749. Enferm Infecc Microbiol Clin. 2007. PMID: 17261243 Spanish.
Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort.
Perez-Hoyos S, Rodríguez-Arenas MA, García de la Hera M, Iribarren JA, Moreno S, Viciana P, Peña A, Gómez Sirvent JL, Saumoy M, Lacruz J, Padilla S, Oteo JA, Asencio R, Del Amo J; CoRIS-MD. Perez-Hoyos S, et al. Among authors: moreno s. J Womens Health (Larchmt). 2007 Sep;16(7):1052-61. doi: 10.1089/jwh.2007.0437. J Womens Health (Larchmt). 2007. PMID: 17903082
Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy.
Gutiérrez F, Padilla S, Masiá M, Iribarren JA, Moreno S, Viciana P, Hernández-Quero J, Alemán R, Vidal F, Salavert M, Blanco JR, Leal M, Dronda F, Perez Hoyos S, del Amo J; CoRIS-MD. Gutiérrez F, et al. Among authors: moreno s. Curr HIV Res. 2008 Mar;6(2):100-7. doi: 10.2174/157016208783885038. Curr HIV Res. 2008. PMID: 18336257
Observational study to evaluate clinical outcomes after first-line efavirenz-or lopinavir-ritonavir-based HAART in treatment-naive patients.
Pérez-Elías MJ, Moreno A, Casado JL, Dronda F, Antela A, López D, Quereda C, Navas E, Hermida JM, Del Sol E, Moreno S. Pérez-Elías MJ, et al. Among authors: moreno s, moreno a. J Int Assoc Physicians AIDS Care (Chic). 2009 Sep-Oct;8(5):308-13. doi: 10.1177/1545109709343965. Epub 2009 Aug 31. J Int Assoc Physicians AIDS Care (Chic). 2009. PMID: 19721095
1,991 results